OPNT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 25.15%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Opiant Pharmaceuticals Insider Trading History Chart

Opiant Pharmaceuticals Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 03/2/2023 09:00 PM ET

The #1 Coin for November 2024

From Crypto 101 Media | Ad

You can get access to the report by clicking here now…

Opiant Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/27/2023	Brian Gorman	General Counsel	Sell	444	$20.26	$8,995.44	31,990
1/27/2023	David D. O'Toole	CFO	Sell	541	$20.26	$10,960.66	34,248
1/27/2023	Mark Jason Heath Ellison	Insider	Sell	610	$20.26	$12,358.60	18,751
1/27/2023	Roger Crystal	CEO	Sell	1,358	$20.26	$27,513.08	75,339
1/9/2023	David D. O'Toole	CFO	Sell	415	$20.20	$8,383.00	34,789
1/9/2023	Mark Jason Heath Ellison	Insider	Sell	469	$20.20	$9,473.80	19,361
1/9/2023	Roger Crystal	CEO	Sell	1,183	$20.20	$23,896.60	76,697
1/5/2023	Brian Gorman	General Counsel	Sell	1,313	$20.20	$26,522.60	32,434
1/5/2023	David D. O'Toole	CFO	Sell	1,600	$20.20	$32,320.00	35,204
1/5/2023	Mark Jason Heath Ellison	Insider	Sell	1,806	$20.20	$36,481.20	19,830
1/5/2023	Roger Crystal	CEO	Sell	5,029	$20.20	$101,585.80	77,880
7/20/2022	Matthew R. Ruth	Insider	Sell	1,084	$10.62	$11,512.08	29,916
7/14/2022	Brian Gorman	General Counsel	Sell	691	$11.16	$7,711.56	33,747
7/14/2022	David D. O'Toole	CFO	Sell	779	$11.10	$8,646.90	36,804
7/14/2022	Phil Skolnick	Insider	Sell	627	$11.85	$7,429.95	23,818
7/14/2022	Roger Crystal	CEO	Sell	2,246	$11.11	$24,953.06	82,909
6/15/2022	Michael Sinclair	Director	Sell	900	$10.60	$9,540.00	19,220
6/13/2022	Craig A Collard	Director	Buy	4,037	$10.94	$44,164.78	53,822
6/10/2022	Craig A Collard	Director	Buy	1,663	$11.50	$19,124.50	49,785
6/6/2022	Michael Sinclair	Director	Sell	7,688	$12.94	$99,482.72	41,532
6/2/2022	Michael Sinclair	Director	Sell	9,736	$13.88	$135,135.68	59,484
1/27/2022	Phil Skolnick	Insider	Sell	1,518	$26.19	$39,756.42
1/27/2022	Roger Crystal	CEO	Sell	1,995	$26.15	$52,169.25
1/10/2022	David D. O'Toole	CFO	Sell	432	$30.60	$13,219.20
1/10/2022	Phil Skolnick	Insider	Sell	385	$30.49	$11,738.65
1/10/2022	Roger Crystal	CEO	Sell	1,058	$30.49	$32,258.42

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

SEC Filings (Institutional Ownership Changes) for Opiant Pharmaceuticals (NASDAQ:OPNT)

42.39% of Opiant Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Opiant Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2023	Fifth Lane Capital LP	15,000	$0.30M	0.3%	N/A	0.291%
2/14/2023	CSS LLC IL	61,349	$1.24M	0.1%	N/A	1.189%
2/13/2023	Gamco Investors INC. ET AL	10,000	$0.20M	0.0%	N/A	0.194%
2/13/2023	Ramius Advisors LLC	55,298	$1.12M	1.1%	N/A	1.071%
2/10/2023	New York Life Investment Management LLC	61,912	$1.26M	0.0%	N/A	1.200%
2/10/2023	Yakira Capital Management Inc.	54,371	$1.10M	0.2%	N/A	1.054%
1/25/2023	Lindbrook Capital LLC	2,000	$41K	0.0%	+300.0%	0.039%
11/15/2022	Parkman Healthcare Partners LLC	76,530	$0.82M	0.2%	+1.2%	1.482%
11/15/2022	Essex Investment Management Co. LLC	47,169	$0.51M	0.1%	-6.4%	0.914%
10/26/2022	Mesirow Financial Investment Management Inc.	17,633	$0.19M	0.9%	N/A	0.342%
8/12/2022	Apis Capital Advisors LLC	196,000	$2.35M	2.6%	+75.0%	3.858%
8/12/2022	Essex Investment Management Co. LLC	50,405	$0.60M	0.1%	+57.3%	0.992%
7/8/2022	HealthInvest Partners AB	210,000	$2.52M	5.8%	+1,066.7%	4.134%
5/13/2022	Parkman Healthcare Partners LLC	32,557	$0.70M	0.2%	+4.0%	0.641%
5/13/2022	Apis Capital Advisors LLC	112,000	$2.40M	2.9%	+1.8%	2.205%
5/13/2022	DLD Asset Management LP	20,000	$0.43M	0.0%	-33.3%	0.394%
5/12/2022	Acadian Asset Management LLC	116,478	$2.49M	0.0%	+62.0%	2.293%
5/11/2022	Ovata Capital Management Ltd	117,865	$2.53M	0.8%	N/A	2.320%
5/9/2022	Essex Investment Management Co. LLC	32,040	$0.69M	0.1%	+2.5%	0.631%
5/5/2022	HealthInvest Partners AB	18,000	$0.39M	0.6%	N/A	0.354%
4/25/2022	Bailard Inc.	15,042	$0.32M	0.0%	-7.4%	0.296%
2/22/2022	DLD Asset Management LP	30,000	$1.01M	0.0%	N/A	0.636%
2/15/2022	DLD Asset Management LP	30,000	$1.01M	0.1%	N/A	0.636%
2/11/2022	Renaissance Technologies LLC	183,815	$6.18M	0.0%	-10.6%	3.894%
2/10/2022	Essex Investment Management Co. LLC	31,263	$1.05M	0.1%	+26.1%	0.662%
2/10/2022	Acadian Asset Management LLC	71,916	$2.42M	0.0%	+11.6%	1.524%
2/9/2022	Dimensional Fund Advisors LP	66,651	$2.24M	0.0%	+51.1%	1.412%
2/7/2022	Hillsdale Investment Management Inc.	3,200	$0.11M	0.0%	N/A	0.068%
2/3/2022	Advisor Group Holdings Inc.	8,125	$0.27M	0.0%	+28.5%	0.172%
1/27/2022	Dorsey Wright & Associates	2,138	$72K	0.0%	N/A	0.045%
1/19/2022	Marquette Asset Management LLC	5,180	$0.17M	0.0%	-34.8%	0.110%
11/16/2021	Two Sigma Advisers LP	83,100	$2.14M	0.0%	N/A	1.889%
11/16/2021	Two Sigma Investments LP	51,045	$1.31M	0.0%	N/A	1.160%
11/12/2021	Renaissance Technologies LLC	205,615	$5.29M	0.0%	+7.5%	4.673%
11/12/2021	Apis Capital Advisors LLC	102,000	$2.63M	2.5%	+21.4%	2.318%
11/12/2021	Parkman Healthcare Partners LLC	30,000	$0.77M	0.2%	N/A	0.682%
11/12/2021	Geode Capital Management LLC	50,244	$1.29M	0.0%	+290.0%	1.142%
11/12/2021	EAM Investors LLC	69,046	$1.78M	0.3%	N/A	1.569%
11/9/2021	Essex Investment Management Co. LLC	24,792	$0.64M	0.1%	N/A	0.563%
11/9/2021	BlackRock Inc.	24,686	$0.64M	0.0%	+107.2%	0.561%
11/5/2021	Advisor Group Holdings Inc.	6,325	$0.16M	0.0%	+102.4%	0.144%
9/7/2021	Newbridge Financial Services Group Inc.	2,500	$33K	0.0%	-52.8%	0.057%
8/17/2021	Wells Fargo & Company MN	251,007	$3.36M	0.0%	+0.4%	5.705%
8/17/2021	Apis Capital Advisors LLC	84,000	$1.12M	1.0%	+5.0%	1.909%
8/13/2021	Renaissance Technologies LLC	191,315	$2.56M	0.0%	-14.1%	4.348%
8/13/2021	Northern Trust Corp	37,958	$0.51M	0.0%	+17.6%	0.863%
8/13/2021	Vanguard Group Inc.	136,965	$1.83M	0.0%	+21.2%	3.113%
5/21/2021	Citadel Advisors LLC	11,110	$0.12M	0.0%	-12.1%	0.257%
5/18/2021	Citadel Advisors LLC	11,110	$0.12M	0.0%	-12.1%	0.257%
5/14/2021	Dimensional Fund Advisors LP	21,831	$0.23M	0.0%	+11.5%	0.504%
5/13/2021	Renaissance Technologies LLC	222,815	$2.37M	0.0%	-5.9%	5.145%
5/12/2021	Northern Trust Corp	32,290	$0.34M	0.0%	-37.5%	0.746%
5/12/2021	Geode Capital Management LLC	12,882	$0.14M	0.0%	N/A	0.297%
5/11/2021	Acadian Asset Management LLC	59,831	$0.64M	0.0%	-1.7%	1.381%
2/16/2021	Apis Capital Advisors LLC	64,000	$0.51M	0.5%	N/A	1.503%
2/11/2021	Northern Trust Corp	51,634	$0.42M	0.0%	-13.6%	1.213%
2/10/2021	Renaissance Technologies LLC	236,815	$1.90M	0.0%	+9.7%	5.562%
2/9/2021	Wells Fargo & Company MN	252,205	$2.03M	0.0%	+21.9%	5.923%
11/16/2020	Squarepoint Ops LLC	12,087	$90K	0.0%	N/A	0.284%
11/13/2020	Morgan Stanley	10,714	$80K	0.0%	+39.1%	0.252%
11/6/2020	BlackRock Inc.	29,491	$0.22M	0.0%	+43.6%	0.693%

Data available starting January 2016

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.

Today's Range

Now: N/A

50 Day Range

MA: $20.58

$20.03

$21.10

52 Week Range

Now: N/A

Volume

562,700 shs

Average Volume

77,920 shs

Market Capitalization

$108.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Opiant Pharmaceuticals?: Opiant Pharmaceuticals' top insider shareholders include:
Roger Crystal (CEO)
David D O'toole (CFO)
Brian Gorman (General Counsel)
Mark Jason Heath Ellison (Insider)
Learn More about top insider investors at Opiant Pharmaceuticals.